(Figure 1b) showed the highest anti-influenza virus activity [15]. Although EGCG-C 16 exhibited a slightly (3.2-fold) higher cytotoxic effect to MDCK cells, it showed significantly (23.5-fold) higher anti-influenza virus activity against the A/Puerto Rico/8/34(H1N1) strain [16]. EGCG-C 16 inhibited human-, swine-and avian-pathogenic influenza A viruses, and the EC 50 was between 10 nM and 61 nM, a 7.1-fold to 44-fold lower concentration than unmodified EGCG [16]. A lethal dose of avian-influenza A/H5N2 virus pretreated with EGCG-C 16 completely prevented the death of embryonated chicken eggs inoculated with the virus by an allantoic cavity route [16].Oliveira et al. reported that EGCG-C 16 inhibited the adsorption step of herpes simplex virus infection in Vero cells [17]. Zhao et al. reported that EGCG-C 16 exhibits significantly higher antiviral activity against porcine reproductive and respiratory syndrome virus than natural EGCG and ribavirin as both pre-treatment and post-treatment [18]. These reports suggest that the pronounced antiviral activities of EGCG-fatty acid derivatives were due to increased permeability through both the viral membrane and the cell membrane.Although EGCG interferes with different types of viral infections, it is easily oxidized or hydrolyzed under physiological conditions because of the reactive hydroxyl groups in the gallyl moiety in the B-ring and the galloyl moiety in the D-ring [19,20]. However, addition of a palmitoyl group to the B-ring or D-ring prolonged its half-life in a cell culture medium approximately seven-fold [21].These improved chemical, biological, and antiviral activities of